BSE filing, NSE: THYROCARE. Summary written from the filing by ALFA Finder's alert engine.
Thyrocare Technologies Ltd: key numbers
- Share price
- ₹456.30
- Market cap
- ₹7,263 Cr
- Revenue (annual)
- ₹829.0 Cr
- Net profit (annual)
- ₹163.0 Cr
- P/E (TTM)
- 50.4×Sector 52.3×
- Promoter holding
- 51.02%-9.90% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thyrocare Technologies Ltd
All →Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr
Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.
- Value
- ₹141.4 Cr
Thyrocare Technologies Annual General Meeting
Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.
Thyrocare Technologies Earnings Call Transcript: Key Takeaways
Thyrocare reports robust 24% growth, pivoting from volume-led routine testing to specialized diagnostics under new management. High operational leverage is evident as PAT growth significantly outpaced revenue.
- Call
- Guides 20% growth
Thyrocare Technologies Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹270.8 Cr (+25.1%), EBITDA ₹89.3 Cr (33.0% margin), PAT before exceptions ₹60.2 Cr (+25.7%). Debt-free; NHL radiology divestment pending.
Thyrocare Technologies Results Update
Thyrocare Technologies reported Q2FY27 consolidated revenue of Rs 270.8 Cr, up 25.1% YoY, with PAT before exceptions of Rs 60.2 Cr. The press release also notes a Rs 45 Cr non-cash NHL impairment tied to a proposed divestment.
Thyrocare Technologies Q2 FY27 Results: Net Profit ₹15.2 Cr, Down 68.2% YoY
Thyrocare Technologies Ltd reported revenue from operations of ₹270.8 Cr (+25.1% YoY) and net profit of ₹15.2 Cr (-68.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹15.2 Cr · -68.2% YoY
Other management change announcements
All →Prataap Snacks Management Change
Prataap Snacks appointed Mr. Jitendra Nayyar as Non-Executive Independent Director and Mr. Sumit Sharma as Additional Executive Director, both for three years from October 30, 2026. Both appointments are subject to shareholder approval.
Neelkanth Rock-Minerals Management Change
Neelkanth Rock-Minerals' CFO Rameshwar Jangid resigned effective 30 October 2026 to pursue other career opportunities. The board accepted the resignation at its meeting held the same day.
Ramkrishna Forgings Management Change
Ramkrishna Forgings appointed Subir Chakraborty and Anurag Vohra as Non-Executive Independent Directors for five-year terms, effective 30 October 2026. The appointments add two independent members to the board.
- Execution
- 60 months (term of appointment for each director)
Tilaknagar Industries Management Change
Tilaknagar Industries appointed Shailesh Tinaikar and Sanjay Saxena as Non-Executive Independent Directors effective 30 October 2026. Independent directors Dilawar Singh and Satish Mathur completed their tenures.
Qualiance International Management Change
Qualiance International appointed Siddharth Gajra as Company Secretary effective 1 November 2026. Tushar Shridharani was appointed Secretarial Auditor for five years.
Naturewings Holidays Management Change
NatureWings Holidays disclosed the resignation of its internal auditor, Rajat Kala & Associates, effective October 28, 2026. The auditor cited pre-occupation and professional commitments, with no other material reasons.